...
首页> 外文期刊>Journal of pharmacology & toxicology. >Antidiabetic Activity and Safety Used of Nutrasucre, a Food Complement, in Alloxan Induced Diabetic Rats
【24h】

Antidiabetic Activity and Safety Used of Nutrasucre, a Food Complement, in Alloxan Induced Diabetic Rats

机译:食物补品Nutrasucre在抗四氧嘧啶诱导的糖尿病大鼠中的抗糖尿病活性和安全性

获取原文

摘要

Background and Objective: Type 2 diabetes is one of the major public health problem arround the world and particularly in Cote d'Ivoire. The relation ship between sugar consumption and type 2 diabetes treatment remained critical to be discovered. Nutrasucre, a food complement containing brown sugar and extracts of medicinal plant s used for the treatment of type 2 diabetes in Cote d?Ivoire. This study aimed nutrasucre?s aptitude to reduce glycemia and its safety used may provide a likely profit by supporting sugar consumption in type 2 diabetes treatment. Materials and Methods: Thirty five diabetics rats received nutrasucre solution at 1.43, 2.86 and 5.71 g kg?1 b.w., respectively. Blood withdrawals were performed at the end of treatment. Biochemical parameters were assessed: Glycemia, urea, creatinine, transaminases (ALAT, ASAT), triglycerides, total cholesterol, HDL cholesterol and LDL cholesterol. Acute and sub acute toxicity were carried out using OECD Guidelines 423 and 407, respectively. Kidneys, heart and liver tissues were collected and subjected to microscopical analysis. One-way analysis of variance (ANOVA 1) and multiple comparisons of Tukey-Kramer post-hoc test were being used. Results: Nutrasucre possessed antihyperglycemic effect comparable to glibenclamide, a reference antihyperglycemic drug and increased triglyceride, total cholesterol, HDL and LDH cholesterols levels. This increase was significant for triglycerides (p50 value of nutrasucre was higher than 5000 mg kg?1 b.w. and was classified as non toxic in the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). No signs of sub acute toxicity were recorded during the 28 observation days. Finally, the repeated administration of nutrasucre did not affect various vital organs. Conclusion: It is concluded that nutrasucre was antihyperglycemic, nontoxic and does not affect vital organs such as kidneys, liver and heart. It reduces serum ASAT, ALAT and total, LDH and HDL levels and contains hypolipidic substances. It can be advised as antidiabetic food complement.
机译:背景与目的:2型糖尿病是世界范围内主要的公共卫生问题之一,尤其是在科特迪瓦。糖消耗与2型糖尿病治疗之间的关系尚待发现。 Nutrasucre,一种食品补充剂,包含红糖和药用植物提取物,用于治疗科特迪瓦的2型糖尿病。这项研究旨在降低营养素降低血糖的能力,其安全性可能通过支持2型糖尿病治疗中的糖消耗来提供可能的收益。材料和方法:35只糖尿病大鼠分别以1.43、2.86和5.71 g kg ?1 b.w.w. w摄入营养盐溶液。在治疗结束时抽血。评估了生化参数:血糖,尿素,肌酐,转氨酶(ALAT,ASAT),甘油三酸酯,总胆固醇,HDL胆固醇和LDL胆固醇。急性和亚急性毒性分别使用经合组织准则423和407进行。收集肾脏,心脏和肝脏组织,并进行显微镜分析。使用单向方差分析(ANOVA 1)和Tukey-Kramer事后检验的多次比较。结果:Nutrasucre具有与格列本脲(一种参考降糖药)相当的降糖作用,并增加了甘油三酸酯,总胆固醇,HDL和LDH胆固醇水平。对于甘油三酸酯而言,这种增加是显着的(营养素的p50 值高于5000 mg kg ?1 bw,并且在全球化学品统一分类和标签制度(GHS)中被归类为无毒的。 )。在28个观察日内没有发现亚急性毒性的迹象,最后,重复服用营养素对各种重要器官均无影响结论:结论:营养素具有降血糖,无毒且不影响肾脏等重要器官的作用。可以降低血清ASAT,ALAT和总胆固醇,LDH和HDL含量,并含有降血脂物质,可作为抗糖尿病食品的补充品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号